PACIRA PHARMACEUTICALS INC's ticker is and the CUSIP is 695127AB6. A total of 12 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $17,117,000 | +10.0% | 11,350,000 | +8.1% | 0.71% | +73.3% |
| Q2 2016 | $15,560,000 | -42.3% | 10,500,000 | -13.9% | 0.41% | -47.6% |
| Q1 2016 | $26,949,000 | -60.6% | 12,194,000 | -44.3% | 0.79% | -57.8% |
| Q4 2015 | $68,327,000 | +75.2% | 21,904,000 | -1.9% | 1.86% | +6.9% |
| Q3 2015 | $38,990,000 | -41.5% | 22,336,000 | -4.5% | 1.74% | -39.6% |
| Q2 2015 | $66,667,000 | +30.3% | 23,397,000 | +63.3% | 2.88% | +46.0% |
| Q1 2015 | $51,147,000 | +11.5% | 14,327,000 | +11.6% | 1.98% | +7.7% |
| Q4 2014 | $45,891,000 | -14.0% | 12,839,000 | -6.0% | 1.84% | -11.3% |
| Q3 2014 | $53,331,000 | +52.1% | 13,657,000 | +45.3% | 2.07% | +49.6% |
| Q2 2014 | $35,066,000 | – | 9,398,000 | – | 1.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EQUITEC SPECIALISTS, LLC | 3,000,000 | $4,524,000 | 1.31% |
| Myriad Asset Management Ltd. | 10,000,000 | $14,880,000 | 0.95% |
| WHITEBOX ADVISORS LLC | 11,350,000 | $17,117,000 | 0.71% |
| WOLVERINE ASSET MANAGEMENT LLC | 21,743,000 | $32,797,000 | 0.49% |
| MIZUHO SECURITIES USA LLC | 3,500,000 | $5,275,000 | 0.44% |
| Verition Fund Management LLC | 1,160,000 | $1,755,000 | 0.19% |
| CSS LLC/IL | 1,500,000 | $2,245,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 982,000 | $1,473,000 | 0.05% |
| Citadel Advisors | 30,050,000 | $45,358,000 | 0.05% |
| LAZARD ASSET MANAGEMENT LLC | 9,000,000 | $13,618,000 | 0.03% |